Manuscripts

Search by keyword, year, or author name.

Showing 1543 manuscripts.

Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy

Jeff D. Moore, Edward P. Acosta, Victoria A. Johnson, Roland Bassett, Joseph J. Eron, Margaret A. Fischl, Mary C. Long, Daniel R. Kuritzkes, Jean-Pierre Sommadossi. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy. Antiviral Therapy. 2007. 12: 981-6.

Year

2007

Journal

Antiviral Therapy

Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions

Susan Ellen Cohn, Jeong-Gun Park, Heather D. Watts, Alice M. Stek, Jane Hitti, Pamela A. Clax, Song Yu, Juan J.L. Lertora. Depo-medroxyprogesterone in women on antiretroviral therapy: effective contraception and lack of clinically significant interactions. Clinical Pharmacology & Therapeutics. 2007. 81: 222-7.

Year

2007

Journal

Clinical Pharmacology & Therapeutics

Viral factors associated with cytokine expression during HCV/HIV co-infection

Jason T. Blackard, Minhee Kang, Benjamin St. Clair, Wenyu Lin, Yoshitaka Kamegaya, Kenneth E. Sherman, Margaret James Koziel, Marion G. Peters, Janet Andersen, Raymond T. Chung. Viral factors associated with cytokine expression during HCV/HIV co-infection. Journal of Interferon and Cytokine Research. 2007. 24: 263-9.

Year

2007

Journal

Journal of Interferon and Cytokine Research

Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.

Marie Louise Newell, Sharon Huang, Simone Fiore, Claire Thorne, Laurent Mandelbrot, John L. Sullivan, Robert T. Maupin, Issac Delke, Heather D. Watts, Richard D. Gelber, Coleen K. Cunningham. Characteristics and management of HIV-1-infected pregnant women enrolled in a randomised trial: differences between Europe and the USA.. BioMed Central Infectious Diseases. 2007. 7: 60. PMID: 17584491

Year

2007

Journal

BioMed Central Infectious Diseases

In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.

Susan Brogly, Nathalie Ylitalo, Lynne M. Mofenson, James M. Oleske, Russell B. Van Dyke, Marilyn Jean Crain, Mark J. Abzug, Michael T. Brady, Patrick Jean-Philippe, Michael Hughes, George Seage. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.. AIDS. 2007. 21: 929-938. PMID: 17457086

Year

2007

Journal

AIDS

Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial.

Courtney V. Fletcher, Richard Brundage, Terence Fenton, Carmelita Alvero, Christine Powell, Lynne M. Mofenson, Stephen A. Spector. Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial.. Clinical Pharmacology & Therapeutics. 2007. 83: 300-6. PMID: 17609682

Year

2007

Journal

Clinical Pharmacology & Therapeutics

Pharmacokinetics of oral zidovudine administered during labor: a preliminary study.

Mark Mirochnick, John H. Rodman, Brian Robbins, Arnold Fridland, Jorge Gandia, Jane Hitti, Arlene D. Bardeguez, Mobeen H. Rathore, Adolfo Gonzalez-Garcia, Mae P. Cababasay, Pearl Samson, Lynne M. Mofenson, Yvonne J. Bryson, Alejandro Dorenbaum. Pharmacokinetics of oral zidovudine administered during labor: a preliminary study.. HIV Medicine. 2007. 8: 451-456. PMID: 17760737

Year

2007

Journal

HIV Medicine

Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease-inhibitor-based highly active antiretroviral therapy.

Jane C. Lindsey, Kathleen Malee, Pim Brouwers, Michael Hughes. Neurodevelopmental functioning in HIV-infected infants and young children before and after the introduction of protease-inhibitor-based highly active antiretroviral therapy.. Pediatrics. 2007. 119: e681 - e693. PMID: 17296781

Year

2007

Journal

Pediatrics

Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.

Savita G. Pahwa, Petronella Muresan, John W. Sleasman, Terence Fenton, John ( Jack ) Moye, Audra Deveikis, Diane W. Wara, Russell B. Van Dyke. Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.. Journal of Allergy and Clinical Immunology. 2007. 119: 1538 - 1541. PMID: 17418382

Year

2007

Journal

Journal of Allergy and Clinical Immunology